Luizza 1/20 Tablet
Product Images NDC 70700-313

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Luizza 1/20 (NDC 70700-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinyl Estradiol And Norethindrone Acetate Structural Formulas (Image 01)

Chemical structure diagram showing the molecular structures of two active ingredients: Ethinyl Estradiol (C20H24O2, molecular weight 296.40) and Norethindrone Acetate (C22H28O3, molecular weight 340.46). The structures display the arrangement of atoms and chemical bonds for each compound.*

FDA Label Image

Table Ii: Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)

A bar chart showing mortality rates (number of deaths per 100,000 woman users) by age groups (15-24, 25-34, 35-44, 45+) categorized by ever-users and controls, split into smokers and non-smokers. The chart includes four data series distinguished by different shading patterns representing ever-users (non-smokers and smokers) and controls (non-smokers and smokers).*

FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)

A forest plot chart comparing the effect estimates (odds ratio, relative risk, hazard ratio) of 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' from various women's health studies. The horizontal axis shows effect estimate values ranging from -1.50 to 2.00, with confidence intervals depicted for each study's results. The chart highlights individual study results related to contraceptive use risks.*

FDA Label Image

Instructions For Use Figure 1 (Image 04)

An instructional pill calendar diagram for Luizza 1/20 (Norethindrone Acetate and Ethinyl Estradiol) tablets, USP 1 mg/20 mcg, showing 21 circular tablet placeholders arranged in three horizontal rows labeled as Week 1, Week 2, and Week 3. Days of the week (Sunday through Saturday) are displayed above each column. Arrows indicate the direction for taking pills from left to right each week. Instructions mention placement of a day label strip for day-1 starters and starting points for Sunday and day-1 starters. The labeler Xiromed, LLC and storage instructions are noted.*

FDA Label Image

Instructions For Use Figure 2 (Image 05)

An instructional diagram showing day label strips for each day of the week, arranged in rows. Users are instructed to pick the strip starting with the first day of their period and overlay it on a blister pack, matching days of the week starting with Sunday. A note advises skipping this step if the period starts on Sunday.*

FDA Label Image

Instructions For Use Figure 3 (Image 06)

An instructional diagram for LUIZZA 1/20 (norethindrone acetate and ethinyl estradiol) oral tablets, showing a 21-tablet weekly calendar pack. It guides the user to start on Sunday or day 1 of their period, taking pills left to right each week from Weeks 1 to 3, with directions for placing a day label strip if starting on a day other than Sunday.*

FDA Label Image

Instructions For Use Figure 4 (Image 07)

An illustrated instruction panel for day label strips used with LUIZZA 1/20 oral tablets. It shows rows of abbreviated weekday names for aligning the label strip with the first day of a menstrual period. Directional text explains starting on day 1 with the first day of the period and placement guidance over the blister days, noting skipping if the period starts on a Sunday.*

FDA Label Image

Norethindrone Acetate And Ethinyl Estradiol Tablets Label (Image 08)

Packaging label for LUIZZA 1/20 tablets, containing norethindrone acetate and ethinyl estradiol. The label indicates a strength of 1 mg/20 mcg per tablet. The product is an oral contraceptive by Xiromed, LLC. The box contains 3 pouches, each with one blister pack of 21 tablets. The label includes NDC 70700-313 and notes that it is prescription-only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.